Breaking News Instant updates and real-time market news.

SQM

SQM

$23.75

-1.15 (-4.62%)

, ALB

Albemarle

$64.60

-0.68 (-1.04%)

14:17
11/13/19
11/13
14:17
11/13/19
14:17

Lithium suppliers fall amid inventory glut in China, 'weak' electric car sales

Shares of Lithium makers including SQM (SQM), Albemarle (ALB), Livent (LTHM), and FMC (FMC) are lower following an Albemarle downgrade by Citi analyst P.J. Juvekar. ELEVATED LITHIUM SUPPLY: Citi analyst P.J. Juvekar downgraded Albemarle to Sell from Neutral with a price target of $58, down from $62. The analyst said he sees elevated inventory in lithium with ~30 kt of surplus carbonate inventory in China. Further, destocking could take another six months or more given "weak" China new electric vehicle sales on the June subsidy cut and the possibility of another subsidy cut in 2020, Juvekar told investors. He believes Albemarle "is feeling contract price pressure" after his lithium industry contacts "show no improvement in sight." FMC CEO SELLS SHARES: On November 1, according to regulatory filings, Pierre Brondeau, the CEO lithium producer FMC, sold over $2.3M shares of company stock. PRICE ACTION: Shares of publicly traded companies with exposure to the lithium market are all down, with Albemarle down almost 1%, Sociedad Quimica y Minera de Chile S.A., or SQM, and Livent losing approximately 5%, and FMC down over 2%.

SQM

SQM

$23.75

-1.15 (-4.62%)

ALB

Albemarle

$64.60

-0.68 (-1.04%)

LTHM

Livent

$7.50

-0.325 (-4.15%)

FMC

FMC Corporation

$96.16

-2.175 (-2.21%)

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 22

    Nov

  • 05

    Dec

  • 06

    Dec

  • 12

    Dec

SQM SQM
$23.75

-1.15 (-4.62%)

08/23/19
BMOC
08/23/19
NO CHANGE
Target $24
BMOC
Market Perform
SQM price target lowered to $24 from $31 at BMO Capital
BMO Capital analyst Joel Jackson lowered his price target on SQM to $24 and kept his Market Perform rating to reflect his reduced price expectations for lithium and potassium nitrate. The analyst contends that the company's expected 2019 EBITDA of about $674M would represent its lowest earnings since 2009, and he expects minimal earnings growth next year given the management's focus on selling lithium "no matter the price". Jackson adds that SQM will remain challenged in lithium from higher supply than demand and continued mix issues.
08/26/19
SBSH
08/26/19
NO CHANGE
Target $25
SBSH
Neutral
SQM price target lowered to $25 from $33 at Citi
In a research note partially titled "Still Too Early," Citi analyst Andrew McCarthy lowered his price target for SQM to $25 from $33 and reiterates a Neutral rating on the shares. It remains too early to get more positive on the stock given the recent "weak" lithium market data and downward consensus earnings revisions ahead, McCarthy tells investors. He sees the stock as fairly valued at current levels.
08/22/19
JPMS
08/22/19
DOWNGRADE
Target $23
JPMS
Underweight
SQM downgraded to Underweight after lithium price forecast cut at JPMorgan
As previously reported, JPMorgan analyst Lucas Ferreira downgraded SQM to Underweight from Neutral after the company "once again" lowered its lithium price forecast citing significant exposure to the deteriorating Chinese market. He sees no short-term resistance to lithium carbonate prices given increasing supply, lower global economic growth and the weaker yuan, said Ferreira, who lowered his price target on SQM shares to $23 from $29.
08/22/19
08/22/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Toll Brothers (TOL) downgraded to Market Perform from Outperform at Wells Fargo with analyst Truman Patterson saying although the shares trade at roughly Book Value, he believes the equity lacks a catalyst over the near-to-intermediate term to drive outperformance. 2. SQM (SQM) downgraded to Underweight from Neutral at JPMorgan with analyst Lucas Ferreira citing significant exposure to the deteriorating Chinese market. 3. Fortis (FTS) downgraded to Neutral from Outperformer at CIBC. 4. Splunk (SPLK) downgraded to Neutral from Outperform at Baird with analyst Rob Oliver citing the company's meaningful OCF reduction that stems from the accelerating move to ratable business and reducing up-front invoice durations. 5. Hemispherx (HEB) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing capital concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ALB Albemarle
$64.60

-0.68 (-1.04%)

11/12/19
RBCM
11/12/19
DOWNGRADE
Target $71
RBCM
Sector Perform
Albemarle downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Arun Viswanathan downgraded Albemarle to Sector Perform from Outperform with a $71 price target.
11/12/19
RBCM
11/12/19
DOWNGRADE
Target $71
RBCM
Sector Perform
Albemarle downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Arun Viswanathan downgraded Albemarle to Sector Perform from Outperform with a price target of $71, down from $77. The analyst notes that with lithium prices falling below historical levels, global lithium suppliers may have to reduce output and wait for demand to catch up. Viswanathan adds that the near-term supply-demand imbalance, along with the general weakness in the auto industry, may keep Albemarle from achieving his previously forecast 40% or more EBITDA margins.
11/12/19
11/12/19
INITIATION

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CSX (CSX) downgraded to Hold from Buy at Deutsche Bank. 2. Eaton (ETN) downgraded to Hold from Buy at HSBC. 3. Amneal Pharmaceuticals (AMRX) downgraded to Underweight from Neutral at JPMorgan with analyst Christopher Schott saying while some of the challenges facing the company appear fixable, like supply penalties and plant utilization, many appear fundamental, a function of the evolving dynamics in the U.S. generics market. 4. Albemarle (ALB) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan saying with lithium prices falling below historical levels, global lithium suppliers may have to reduce output and wait for demand to catch up. 5. Box (BOX) downgraded to Market Perform from Outperform at JMP Securities with analyst Erik Suppiger citing concerns that after the challenging October quarter, the pipeline of the company's business has slowed. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/19
SBSH
11/13/19
DOWNGRADE
Target $58
SBSH
Sell
Albemarle downgraded to Sell from Neutral at Citi
Citi analyst P.J. Juvekar downgraded Albemarle to Sell from Neutral with a price target of $58, down from $62. The analyst sees elevated inventory in lithium with ~30 kt of surplus carbonate inventory in China. Further, destocking could take another six months or more given "weak" China new electric vehicle sales on the June subsidy cut and the possibility of another subsidy cut in 2020, Juvekar tells investors in a research note. He believes Albemarle "is feeling contract price pressure" after his lithium industry contacts "show no improvement in sight."
LTHM Livent
$7.50

-0.325 (-4.15%)

05/16/19
ARGS
05/16/19
DOWNGRADE
ARGS
Hold
Livent downgraded to Hold from Buy at Argus
Argus analyst Bill Selesky downgraded Livent to Hold after its Q1 earnings last week, saying the management has forecasted weaker demand and pricing for its high-performance lithium hydroxide amid rising uncertainty around electric vehicle subsidies in China. The analyst further cites the company's forecast of no pricing recovery until late 2019 or early 2020 and its guidance cut, also lowering his FY19 EPS view to 61c from $1.09. Selesky maintains his forecast of FY20 EPS at $1.20 given his expectations for a rebound in lithium pricing.
08/12/19
BOFA
08/12/19
DOWNGRADE
Target $7
BOFA
Underperform
Livent downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Steve Byrne downgraded Livent to Underperform from Neutral and lowered his price target for the shares to $7 from $10. The stock has rallied 34% over the past three trading days despite reporting an inline Q2, Byrne tells investors in a research note. The analyst, however, believes the lithium hydroxide market for electric vehicles may not have enough growth to absorb the new capacity coming over the next 6-12 months. He sees increased risk that Livent's lithium hydroxide production will continue at "challenged economics."
05/22/19
LOOP
05/22/19
NO CHANGE
Target $12
LOOP
Buy
Livent has 'greater value' despite adverse 2019 dynamics, says Loop Capital
Loop Capital analyst Chris Kapsch kept his Buy rating and $12 price target on Livent after meeting with its management this week, saying that while the company's recent "reset" of 2019 EBITDA expectations was "disappointing", he sees the stock remaining supported by the lithium industry's longer-term growth story remaining intact. The analyst expects Livent to become a "more meaningful beneficiary" of the industry's "attractive and sustainable" annualized revenue growth rate of over 20% and, based on the management commentary, believes that an inflection in lithium fundamentals is coming next year.
10/23/19
GSCO
10/23/19
NO CHANGE
Target $85
GSCO
Buy
Buy Albemarle and Livent on 'compelling' contrarian call, says Goldman Sachs
The combination of sharp spot lithium price declines and elevated investor skepticism makes the setup for a contrarian call on shares of Albemarle (ALB) and Livent (LTHM) "compelling," Goldman Sachs analyst Robert Koort tells investors in a research note. The current negative sentiment and spot price plunge have run counter to Albemarle's fundamentals, where consensus estimates have remained relatively flat, adds the analyst. Koort believes lithium prices are approaching a bottom given limited cash margins for the marginal producers. This indicates investors "should dust off their lithium files and consider preparing for an upturn," contends the analyst. Despite lowering his price target for Albemarle to $85 from $96 and for Livent to $8.50 from $9.00, Koort sees "compelling value" in both Buy-rated names.
FMC FMC Corporation
$96.16

-2.175 (-2.21%)

10/31/19
BUCK
10/31/19
NO CHANGE
Target $105
BUCK
Buy
FMC Corporation price target raised to $105 from $100 at Buckingham
Buckingham analyst Dmitry Silversteyn raised his price target for FMC Corporation to $105 from $100 and reiterated a Buy rating, saying he sees significant upside following another beat and raise quarter driven by double-digit organic sales growth led by LATAM, India, China and Pakistan.
10/31/19
SBSH
10/31/19
NO CHANGE
Target $103
SBSH
Buy
Citi names FMC top pick in Ag, boosts target to $103 from $98
Citi analyst P.J. Juvekar raised his price target for FMC Corporation (FMC) to $103 from $98 saying the company reported "an all-round robust quarter," with growth across most geographies and segments. FMC is now the analyst's top pick in Agriculture, followed by Nutrien (NTR) then CF Industries (CF). He keeps a Buy rating on FMC. Ag chemicals is a better market than fertilizers, which tend to be commoditized, Juvekar tells investors in a research note.
10/16/19
10/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Underweight at Atlantic Equities. 2. FMC Corporation (FMC) upgraded to Outperform from Neutral at Baird with analyst Ben Kallo saying he believes FMC's new product introductions, expected share gains in key markets, and operating leverage can drive revenue and adjusted EBITDA growth in 2020 and beyond. 3. Pure Storage (PSTG) upgraded to Outperform from Market Perform at Raymond James with analyst Simon Leopold saying recent VAR/Distributor checks have reflected positive sentiment suggesting Pure can exceed current Street estimates and he has gained a greater appreciation for the market expansion offered by the new FlashArray//C. 4. PDF Solutions (PDFS) upgraded to Buy from Hold at Craig-Hallum with analyst Christian Schwab saying PDF Solutions is transitioning the company to an analytics software model, and believes that looking out 3-5 years, and in line with management's long term model shared at the company's Analyst Day, it can become a "Rule of 40" SaaS like company with 70% gross margins and in aggregate a 20% top line growth rate and 20% operating margin. 5. Builders FirstSource (BLDR) and BMC Stock Holdings (BMCH) upgraded to Overweight from Equal Weight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/19
BARD
10/16/19
UPGRADE
Target $95
BARD
Outperform
Baird upgrades 'safe-haven' FMC Corporation to Outperform
As previously reported, Baird analyst Ben Kallo upgraded FMC Corporation to Outperform from Neutral with a price target of $95, up from $86. He believes FMC's new product introductions, expected share gains in key markets, and operating leverage can drive revenue and adjusted EBITDA growth in 2020 and beyond, Kallo tells investors. He also sees the company's free cash flow generation allowing it to return cash to shareholders and/or invest in growth, potentially via M&A, he said. Given that he believes FMC's growth is not as tied to the global business cycle as specialty chemical peers, Kallo thinks the stock could be a "safe-haven," he added.

TODAY'S FREE FLY STORIES

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

, PYPL

PayPal

$107.68

2.01 (1.90%)

13:57
12/14/19
12/14
13:57
12/14/19
13:57
Periodicals
PNC clients having trouble connecting to PayPal's Venmo, WSJ reports »

Many of PNC…

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

PYPL

PayPal

$107.68

2.01 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 15

    Jan

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

, CMCSA

Comcast

$43.59

0.57 (1.33%)

07:44
12/14/19
12/14
07:44
12/14/19
07:44
Periodicals
Berkshire, Anthem among Barron's top 10 stock picks for 2020 »

Barron's has…

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

RDS.B

Royal Dutch Shell

$57.41

-0.19 (-0.33%)

RDS.A

Royal Dutch Shell

$57.44

-0.32 (-0.55%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

VIAC

ViacomCBS

$38.62

0.83 (2.20%)

ANTM

Anthem

$284.14

-0.405 (-0.14%)

DELL

Dell Technologies

$49.39

-0.11 (-0.22%)

GOOG

Alphabet

$1,348.07

-2.09 (-0.15%)

GOOGL

Alphabet Class A

$1,347.11

-1.4 (-0.10%)

UHAL

Amerco

$360.28

7.57 (2.15%)

UTX

United Technologies

$148.99

-0.5 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Feb

PCG

PG&E

$11.26

-0.49 (-4.17%)

07:38
12/14/19
12/14
07:38
12/14/19
07:38
Hot Stocks
California Governor says PG&E restructuring plan 'falls woefully short' »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

MYGN

Myriad Genetics

$25.58

0.58 (2.32%)

07:31
12/14/19
12/14
07:31
12/14/19
07:31
Hot Stocks
Myriad Genetics says study validates polygenic risk score for breast cancer »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPC

Tutor Perini

$15.73

-0.17 (-1.07%)

07:30
12/14/19
12/14
07:30
12/14/19
07:30
Hot Stocks
Tutor Perini 'disappointed,' will appeal jury verdict in SR 99 Alaskan Way case »

Tutor Perini released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

, BD

Budget Group

$0.00

(0.00%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
European Society for Medical Oncology to hold a conference »

ESMO Immuno-Oncology…

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

BD

Budget Group

$0.00

(0.00%)

IDRA

Idera Pharmaceuticals

$1.59

-0.05 (-3.05%)

MRK

Merck

$89.18

0.84 (0.95%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

NKTR

Nektar

$21.28

-0.53 (-2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ATNX

Athenex

$14.56

-2.38 (-14.05%)

, MRK

Merck

$89.18

0.84 (0.95%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Society of Surgical Oncology to hold a symposium »

San Antonio Breast Cancer…

ATNX

Athenex

$14.56

-2.38 (-14.05%)

MRK

Merck

$89.18

0.84 (0.95%)

ONCS

OncoSec

$2.00

-0.39 (-16.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

, CRON

Cronos Group

$7.28

-0.03 (-0.41%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
MJBizDaily to hold a conference »

Marijuana Business…

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

CRON

Cronos Group

$7.28

-0.03 (-0.41%)

NFX

Newfield Exploration

$0.00

(0.00%)

CGC

Canopy Growth

$20.69

-0.455 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDSI

BioDelivery Sciences

$6.40

-0.065 (-1.01%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
BioDelivery Sciences management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.